{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:13:29Z","timestamp":1792548809072,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11910-017-0780-8","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:35:47Z","timestamp":1500597347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["New Genes Causing Hereditary Parkinson\u2019s Disease or Parkinsonism"],"prefix":"10.1007","volume":"17","author":[{"given":"Andreas","family":"Puschmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"issue":"Suppl 1","key":"780_CR1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1353-8020(13)70009-9","volume":"20","author":"V Bonifati","year":"2014","unstructured":"Bonifati V. Genetics of Parkinson\u2019s disease\u2014state of the art, 2013. Parkinsonism Relat Disord. 2014;20(Suppl 1):S23\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"780_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","volume":"19","author":"A Puschmann","year":"2013","unstructured":"Puschmann A. Monogenic Parkinson\u2019s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord. 2013;19(4):407\u201315.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"780_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Mov Disord. 2013;28(1):14\u201323.","journal-title":"Mov Disord"},{"key":"780_CR4","unstructured":"Puschmann A, Wszolek Z. Genotype-phenotype correlations in Parkinson disease. In: LeDoux MS, editor. Movement disorders: genetics and models. 2 ed. Elsevier; 2013."},{"issue":"6","key":"780_CR5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM. Genetics of Parkinson\u2019s disease. Mol Cell Probes. 2016;30(6):386\u201396.","journal-title":"Mol Cell Probes"},{"issue":"3","key":"780_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.12616","volume":"135","author":"M Ferreira","year":"2017","unstructured":"Ferreira M, Massano J. An updated review of Parkinson\u2019s disease genetics and clinicopathological correlations. Acta Neurol Scand. 2017;135(3):273\u201384.","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"780_CR7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","volume":"23","author":"C Vilarino-Guell","year":"2014","unstructured":"\u2022\u2022 Vilarino-Guell C, Rajput A, Milnerwood AJ, Shah B, Szu-Tu C, Trinh J, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet. 2014;23(7):1794\u2013801. In this article, Vilari\u00f1o-G\u00fcell et al. describe the first discovery of variants in DNAJC13 as causes of PD.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"780_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.26064","volume":"30","author":"EK Gustavsson","year":"2015","unstructured":"Gustavsson EK, Trinh J, Guella I, Vilarino-Guell C, Appel-Cresswell S, Stoessl AJ, et al. DNAJC13 genetic variants in parkinsonism. Mov Disord. 2015;30(2):273\u20138.","journal-title":"Mov Disord"},{"issue":"4","key":"780_CR9","doi-asserted-by":"crossref","first-page":"935.e1","DOI":"10.1016\/j.neurobiolaging.2013.09.018","volume":"35","author":"JN Foo","year":"2014","unstructured":"Foo JN, Liany H, Tan LC, Au WL, Prakash KM, Liu J, et al. DNAJ mutations are rare in Chinese Parkinson\u2019s disease patients and controls. Neurobiol Aging. 2014;35(4):935.e1\u20132.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"780_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ene.12770","volume":"22","author":"O Lorenzo-Betancor","year":"2015","unstructured":"Lorenzo-Betancor O, Ogaki K, Soto-Ortolaza AI, Labbe C, Walton RL, Strongosky AJ, et al. DNAJC13 p.Asn855Ser mutation screening in Parkinson\u2019s disease and pathologically confirmed Lewy body disease patients. Eur J Neurol. 2015;22(9):1323\u20135.","journal-title":"Eur J Neurol"},{"key":"780_CR11","doi-asserted-by":"crossref","first-page":"212.e13","DOI":"10.1016\/j.neurobiolaging.2016.04.023","volume":"45","author":"JP Ross","year":"2016","unstructured":"Ross JP, Dupre N, Dauvilliers Y, Strong S, Ambalavanan A, Spiegelman D, et al. Analysis of DNAJC13 mutations in French-Canadian\/French cohort of Parkinson's disease. Neurobiol Aging. 2016;45:212.e13\u20137.","journal-title":"Neurobiol Aging"},{"issue":"13","key":"780_CR12","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/mds.26019","volume":"29","author":"S Appel-Cresswell","year":"2014","unstructured":"Appel-Cresswell S, Rajput AH, Sossi V, Thompson C, Silva V, McKenzie J, et al. Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S parkinsonism. Mov Disord. 2014;29(13):1684\u20137.","journal-title":"Mov Disord"},{"issue":"3","key":"780_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","volume":"14","author":"M Funayama","year":"2015","unstructured":"\u2022\u2022 Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015;14(3):274\u201382. This paper describes Funayama et al.\u2019s discovery of CHCHD2 mutations as the cause for dominant PD, and, in one patient, tremor only.","journal-title":"Lancet Neurol"},{"key":"780_CR14","doi-asserted-by":"crossref","first-page":"217 e9","DOI":"10.1016\/j.neurobiolaging.2015.10.040","volume":"38","author":"CH Shi","year":"2016","unstructured":"Shi CH, Mao CY, Zhang SY, Yang J, Song B, Wu P, et al. CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease. Neurobiol Aging. 2016;38:217 e9\u201313.","journal-title":"Neurobiol Aging"},{"key":"780_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jns.2016.08.042","volume":"369","author":"CY Mao","year":"2016","unstructured":"Mao CY, Wu P, Zhang SY, Yang J, Liu YT, Zuo CT, et al. Brain glucose metabolism changes in Parkinson\u2019s disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging. J Neurol Sci. 2016;369:303\u20135.","journal-title":"J Neurol Sci"},{"issue":"6","key":"780_CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1212\/WNL.0000000000002361","volume":"86","author":"E Koschmidder","year":"2016","unstructured":"Koschmidder E, Weissbach A, Bruggemann N, Kasten M, Klein C, Lohmann K. A nonsense mutation in CHCHD2 in a patient with Parkinson disease. Neurology. 2016;86(6):577\u20139.","journal-title":"Neurology"},{"issue":"7","key":"780_CR17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(15)00094-0","volume":"14","author":"IE Jansen","year":"2015","unstructured":"Jansen IE, Bras JM, Lesage S, Schulte C, Gibbs JR, Nalls MA, et al. CHCHD2 and Parkinson\u2019s disease. Lancet Neurol. 2015;14(7):678\u20139.","journal-title":"Lancet Neurol"},{"issue":"23","key":"780_CR18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1212\/WNL.0000000000002170","volume":"85","author":"K Ogaki","year":"2015","unstructured":"Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbe C, et al. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. Neurology. 2015;85(23):2016\u201325.","journal-title":"Neurology"},{"issue":"7","key":"780_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(15)00098-8","volume":"14","author":"JN Foo","year":"2015","unstructured":"Foo JN, Liu J, Tan EK. CHCHD2 and Parkinson\u2019s disease. Lancet Neurol. 2015;14(7):681\u20132.","journal-title":"Lancet Neurol"},{"key":"780_CR20","doi-asserted-by":"crossref","first-page":"169 e5","DOI":"10.1016\/j.neurobiolaging.2016.10.022","volume":"50","author":"M Gagliardi","year":"2017","unstructured":"Gagliardi M, Iannello G, Colica C, Annesi G, Quattrone A. Analysis of CHCHD2 gene in familial Parkinson\u2019s disease from Calabria. Neurobiol Aging. 2017;50:169 e5\u20136.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"780_CR21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(15)00095-2","volume":"14","author":"A Puschmann","year":"2015","unstructured":"Puschmann A, Dickson DW, Englund E, Wszolek ZK, Ross OA. CHCHD2 and Parkinson\u2019s disease. Lancet Neurol. 2015;14(7):679.","journal-title":"Lancet Neurol"},{"key":"780_CR22","doi-asserted-by":"crossref","first-page":"218 e9","DOI":"10.1016\/j.neurobiolaging.2016.10.001","volume":"49","author":"C Gao","year":"2017","unstructured":"Gao C, Chen YM, Sun Q, He YC, Huang P, Wang T, et al. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson\u2019s disease patients. Neurobiol Aging. 2017;49:218 e9\u2013e11.","journal-title":"Neurobiol Aging"},{"key":"780_CR23","doi-asserted-by":"crossref","first-page":"169 e1","DOI":"10.1016\/j.neurobiolaging.2016.10.019","volume":"50","author":"C Tejera-Parrado","year":"2017","unstructured":"Tejera-Parrado C, Jesus S, Huertas-Fernandez I, Bernal-Bernal I, Bonilla-Toribio M, Cordoba-Tevar I, et al. Genetic analysis of CHCHD2 in a southern Spanish population. Neurobiol Aging. 2017;50:169 e1\u20132.","journal-title":"Neurobiol Aging"},{"key":"780_CR24","doi-asserted-by":"crossref","first-page":"217 e7","DOI":"10.1016\/j.neurobiolaging.2015.10.038","volume":"38","author":"M Zhang","year":"2016","unstructured":"Zhang M, Xi Z, Fang S, Ghani M, Sato C, Moreno D, et al. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson\u2019s disease. Neurobiol Aging. 2016;38:217 e7\u20138.","journal-title":"Neurobiol Aging"},{"key":"780_CR25","doi-asserted-by":"crossref","first-page":"193 e7","DOI":"10.1016\/j.neurobiolaging.2016.12.027","volume":"53","author":"E Rubino","year":"2017","unstructured":"Rubino E, Brusa L, Zhang M, Boschi S, Govone F, Vacca A, et al. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson\u2019s disease. Neurobiol Aging. 2017;53:193 e7\u20138.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"780_CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jmedgenet-2015-103616","volume":"53","author":"S Sudhaman","year":"2016","unstructured":"Sudhaman S, Muthane UB, Behari M, Govindappa ST, Juyal RC, Thelma BK. Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson\u2019s disease with non-motor phenotypes. J Med Genet. 2016;53(8):559\u201366.","journal-title":"J Med Genet"},{"key":"780_CR27","doi-asserted-by":"crossref","first-page":"194 e9","DOI":"10.1016\/j.neurobiolaging.2017.01.005","volume":"53","author":"JP Ross","year":"2017","unstructured":"Ross JP, Dupre N, Dauvilliers Y, Strong S, Dionne-Laporte A, Dion PA, et al. RIC3 variants are not associated with Parkinson\u2019s disease in French-Canadians and French. Neurobiol Aging. 2017;53:194 e9\u2013e11.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"780_CR28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng.3589","volume":"48","author":"HX Deng","year":"2016","unstructured":"\u2022\u2022 Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, et al. Identification of TMEM230 mutations in familial Parkinson\u2019s disease. Nat Genet. 2016;48(7):733\u20139. In this article, Deng et al. provide their results on the analysis of the same Canadian Mennonite kindred where Vilari\u00f1o-G\u00fcell et al. previously found mutations in DNAJC13 to be causative.","journal-title":"Nat Genet"},{"key":"780_CR29","doi-asserted-by":"publisher","unstructured":"Mandemakers W, Quadri M, Stamelou M, Bonifati V. TMEM230: how does it fit in the etiology and pathogenesis of Parkinson\u2019s disease. Mov Disord. 2017; doi:\n10.1002\/mds.27061\n\n.","DOI":"10.1002\/mds.27061"},{"key":"780_CR30","doi-asserted-by":"crossref","first-page":"167 e11","DOI":"10.1016\/j.neurobiolaging.2016.10.004","volume":"50","author":"A Giri","year":"2017","unstructured":"Giri A, Mok KY, Jansen I, Sharma M, Tesson C, Mangone G, et al. Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson\u2019s disease in the Caucasian population. Neurobiol Aging. 2017;50:167 e11\u20133.","journal-title":"Neurobiol Aging"},{"key":"780_CR31","doi-asserted-by":"crossref","first-page":"219 e1","DOI":"10.1016\/j.neurobiolaging.2016.10.007","volume":"49","author":"W Yan","year":"2017","unstructured":"Yan W, Tang B, Zhou X, Lei L, Li K, Sun Q, et al. TMEM230 mutation analysis in Parkinson\u2019s disease in a Chinese population. Neurobiol Aging. 2017;49:219 e1\u20133.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"780_CR32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mds.26900","volume":"32","author":"M Quadri","year":"2017","unstructured":"Quadri M, Breedveld GJ, Chang HC, Yeh TH, Guedes LC, Toni V, et al. Mutations in TMEM230 are not a common cause of Parkinson\u2019s disease. Mov Disord. 2017;32(2):302\u20134.","journal-title":"Mov Disord"},{"issue":"1","key":"780_CR33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41598-017-01398-9","volume":"7","author":"CH Shi","year":"2017","unstructured":"Shi CH, Li F, Shi MM, Yang ZH, Mao CY, Zhang SY, et al. Genetic analysis of the TMEM230 gene in Chinese Han patients with Parkinson\u2019s disease. Sci Rep. 2017;7(1):1190.","journal-title":"Sci Rep"},{"issue":"5","key":"780_CR34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.26996","volume":"32","author":"X Yang","year":"2017","unstructured":"Yang X, An R, Xi J, Zheng J, Chen Y, Huang H, et al. Sequencing TMEM230 in Chinese patients with sporadic or familial Parkinson\u2019s disease. Mov Disord. 2017;32(5):800\u20132.","journal-title":"Mov Disord"},{"key":"780_CR35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2016.12.021","volume":"36","author":"H Wu","year":"2017","unstructured":"Wu H, Zheng X, Cen Z, Xie F, Chen Y, Lu X, et al. Genetic analysis of the TMEM230 gene in Chinese patients with familial Parkinson disease. Parkinsonism Relat Disord. 2017;36:105\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"780_CR36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2016.12.015","volume":"35","author":"H Baumann","year":"2017","unstructured":"Baumann H, Wolff S, Munchau A, Hagenah JM, Lohmann K, Klein C. Evaluating the role of TMEM230 variants in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;35:100\u20131.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"780_CR37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mds.26875","volume":"32","author":"YC He","year":"2017","unstructured":"He YC, Huang P, Li QQ, Sun Q, Li DH, Wang T, et al. TMEM230 stop codon mutation is rare in Parkinson\u2019s disease and essential tremor in eastern China. Mov Disord. 2017;32(2):301\u20132.","journal-title":"Mov Disord"},{"key":"780_CR38","doi-asserted-by":"publisher","unstructured":"Ibanez L, Dube U, Budde J, Black K, Medvedeva A, Davis AA, et al. TMEM230 in Parkinson\u2019s disease. Neurobiol Aging. 2017; doi:\n10.1016\/j.neurobiolaging.2017.03.014\n\n.","DOI":"10.1016\/j.neurobiolaging.2017.03.014"},{"key":"780_CR39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2017.03.007","volume":"39","author":"G Buongarzone","year":"2017","unstructured":"Buongarzone G, Monfrini E, Franco G, Trezzi I, Borellini L, Frattini E, et al. Mutations in TMEM230 are rare in autosomal dominant Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;39:87\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"780_CR40","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","volume":"1","author":"DM McDonald-McGinn","year":"2015","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"780_CR41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.4065\/73.10.956","volume":"73","author":"LE Krahn","year":"1998","unstructured":"Krahn LE, Maraganore DM, Michels VV. Childhood-onset schizophrenia associated with parkinsonism in a patient with a microdeletion of chromosome 22. Mayo Clin Proc. 1998;73(10):956\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"780_CR42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajmg.a.32650","volume":"149A","author":"C Zaleski","year":"2009","unstructured":"Zaleski C, Bassett AS, Tam K, Shugar AL, Chow EW, McPherson E. The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome. Am J Med Genet A. 2009;149A(3):525\u20138.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"780_CR43","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/ajmg.a.33665","volume":"152A","author":"J Booij","year":"2010","unstructured":"Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging. Am J Med Genet A. 2010;152A(11):2937\u20138.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"780_CR44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2013.3646","volume":"70","author":"NJ Butcher","year":"2013","unstructured":"Butcher NJ, Kiehl TR, Hazrati LN, Chow EW, Rogaeva E, Lang AE, et al. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol. 2013;70(11):1359\u201366.","journal-title":"JAMA Neurol"},{"issue":"9","key":"780_CR45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mds.26305","volume":"30","author":"AF Rehman","year":"2015","unstructured":"Rehman AF, Dhamija R, Williams ES, Barrett MJ. 22q11.2 deletion syndrome presenting with early-onset Parkinson\u2019s disease. Mov Disord. 2015;30(9):1289\u201390.","journal-title":"Mov Disord"},{"issue":"3","key":"780_CR46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ajmg.a.36928","volume":"167a","author":"E Boot","year":"2015","unstructured":"Boot E, Butcher NJ, van Amelsvoort TA, Lang AE, Marras C, Pondal M, et al. Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2015;167a(3):639\u201345.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"780_CR47","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/mds.26822","volume":"31","author":"JN Foo","year":"2016","unstructured":"Foo JN, Lee J, Tan LC, Liu J, Tan EK. Large 3-Mb deletions at 22q11.2 locus in Parkinson\u2019s disease and schizophrenia. Mov Disord. 2016;31(12):1924\u20135.","journal-title":"Mov Disord"},{"issue":"3","key":"780_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2169\/internalmedicine.55.5485","volume":"55","author":"M Oki","year":"2016","unstructured":"Oki M, Hori S, Asayama S, Wate R, Kaneko S, Kusaka H. Early-onset Parkinson\u2019s disease associated with chromosome 22q11.2 deletion syndrome. Intern Med. 2016;55(3):303\u20135.","journal-title":"Intern Med"},{"key":"780_CR49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2016.01.027","volume":"25","author":"R Pollard","year":"2016","unstructured":"Pollard R, Hannan M, Tanabe J, Berman BD. Early-onset Parkinson disease leading to diagnosis of 22q11.2 deletion syndrome. Parkinsonism Relat Disord. 2016;25:110\u20131.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"780_CR50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1474-4422(16)00071-5","volume":"15","author":"KY Mok","year":"2016","unstructured":"Mok KY, Sheerin U, Simon-Sanchez J, Salaka A, Chester L, Escott-Price V, et al. Deletions at 22q11.2 in idiopathic Parkinson\u2019s disease: a combined analysis of genome-wide association data. Lancet Neurol. 2016;15(6):585\u201396.","journal-title":"Lancet Neurol"},{"issue":"9","key":"780_CR51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.parkreldis.2014.06.020","volume":"20","author":"K Ogaki","year":"2014","unstructured":"Ogaki K, Ross OA. Chromosome 22q11.2 deletion may contain a locus for recessive early-onset Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20(9):945\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"780_CR52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","volume":"34","author":"M Quadri","year":"2013","unstructured":"\u2022\u2022 Quadri M, Fang M, Picillo M, Olgiati S, Breedveld GJ, Graafland J, et al. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism. Hum Mutat. 2013;34(9):1208\u201315. In these two papers, published back-to-back, Quadri et al. and Krebs et al. provide independent evidence that mutations in SYNJ1 cause a neurological syndrome with Parkinsonism, dystonia, cognitive decline, and seizures.","journal-title":"Hum Mutat"},{"issue":"9","key":"780_CR53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","volume":"34","author":"CE Krebs","year":"2013","unstructured":"\u2022\u2022 Krebs CE, Karkheiran S, Powell JC, Cao M, Makarov V, Darvish H, et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures. Hum Mutat. 2013;34(9):1200\u20137. In these two papers, published back-to-back, Quadri et al. and Krebs et al. provide independent evidence that mutations in SYNJ1 cause a neurological syndrome with Parkinsonism, dystonia, cognitive decline, and seizures.","journal-title":"Hum Mutat"},{"issue":"4","key":"780_CR54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00415-014-7270-6","volume":"261","author":"M Picillo","year":"2014","unstructured":"Picillo M, Ranieri A, Orefice G, Bonifati V, Barone P. Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family. J Neurol. 2014;261(4):823\u20134.","journal-title":"J Neurol"},{"issue":"3","key":"780_CR55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10048-014-0406-0","volume":"15","author":"S Olgiati","year":"2014","unstructured":"Olgiati S, De Rosa A, Quadri M, Criscuolo C, Breedveld GJ, Picillo M, et al. PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family. Neurogenetics. 2014;15(3):183\u20138.","journal-title":"Neurogenetics"},{"key":"780_CR56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.parkreldis.2015.12.006","volume":"23","author":"A Rosa De","year":"2016","unstructured":"De Rosa A, Pellegrino T, Pappata S, Lieto M, Bonifati V, Palma V, et al. Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism. Parkinsonism Relat Disord. 2016;23:102\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"780_CR57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2016.07.014","volume":"31","author":"L Kirola","year":"2016","unstructured":"Kirola L, Behari M, Shishir C, Thelma BK. Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile parkinsonism. Parkinsonism Relat Disord. 2016;31:124\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"780_CR58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.26876","volume":"32","author":"MA Rauschendorf","year":"2017","unstructured":"Rauschendorf MA, Jost M, Stock F, Zimmer A, Rosler B, Rijntjes M, et al. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome. Mov Disord. 2017;32(3):478\u201380.","journal-title":"Mov Disord"},{"issue":"2","key":"780_CR59","doi-asserted-by":"crossref","first-page":"1222.e1","DOI":"10.1016\/j.neurobiolaging.2014.09.005","volume":"36","author":"DA Dyment","year":"2015","unstructured":"Dyment DA, Smith AC, Humphreys P, Schwartzentruber J, Beaulieu CL, Bulman DE, et al. Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology. Neurobiol Aging. 2015;36(2):1222.e1\u20135.","journal-title":"Neurobiol Aging"},{"issue":"Pt 9","key":"780_CR60","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/brain\/aww180","volume":"139","author":"K Hardies","year":"2016","unstructured":"Hardies K, Cai Y, Jardel C, Jansen AC, Cao M, May P, et al. Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline. Brain. 2016;139(Pt 9):2420\u201330.","journal-title":"Brain"},{"key":"780_CR61","doi-asserted-by":"publisher","unstructured":"Taghavi S, Chaouni R, Tafakhori A, Azcona LJ, Firouzabadi SG, Omrani MD, et al. A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations. Mol Neurobiol. 2017; doi:\n10.1007\/s12035-017-0535-1\n\n.","DOI":"10.1007\/s12035-017-0535-1"},{"issue":"6","key":"780_CR62","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","volume":"95","author":"GR Wilson","year":"2014","unstructured":"\u2022\u2022 Wilson GR, Sim JC, McLean C, Giannandrea M, Galea CA, Riseley JR, et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology. Am J Hum Genet. 2014;95(6):729\u201335. This paper describes the identification of RAB39B mutations as the cause for X-linked Parkinsonism with severe intellectual disability.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"780_CR63","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150\u20137.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"780_CR64","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1353-8020(11)70010-4","volume":"18","author":"A Puschmann","year":"2012","unstructured":"Puschmann A, Bhidayasiri R, Weiner WJ. Synucleinopathies from bench to bedside. Parkinsonism Relat Disord. 2012;18(Suppl 1):S24\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"780_CR65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ajmg.1320210409","volume":"21","author":"R Laxova","year":"1985","unstructured":"Laxova R, Brown ES, Hogan K, Hecox K, Opitz JM. An X-linked recessive basal ganglia disorder with mental retardation. Am J Med Genet. 1985;21(4):681\u20139.","journal-title":"Am J Med Genet"},{"issue":"4","key":"780_CR66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0888-7543(91)90363-J","volume":"9","author":"RG Gregg","year":"1991","unstructured":"Gregg RG, Metzenberg AB, Hogan K, Sekhon G, Laxova R. Waisman syndrome, a human X-linked recessive basal ganglia disorder with mental retardation: localization to Xq27.3-qter. Genomics. 1991;9(4):701\u20136.","journal-title":"Genomics"},{"issue":"5","key":"780_CR67","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1096-8628(20001023)94:5<376::AID-AJMG6>3.0.CO;2-A","volume":"94","author":"S Russo","year":"2000","unstructured":"Russo S, Cogliati F, Cavalleri F, Cassitto MG, Giglioli R, Toniolo D, et al. Mapping to distal Xq28 of nonspecific X-linked mental retardation MRX72: linkage analysis and clinical findings in a three-generation Sardinian family. Am J Med Genet. 2000;94(5):376\u201382.","journal-title":"Am J Med Genet"},{"issue":"2","key":"780_CR68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajhg.2010.01.011","volume":"86","author":"M Giannandrea","year":"2010","unstructured":"Giannandrea M, Bianchi V, Mignogna ML, Sirri A, Carrabino S, D'Elia E, et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet. 2010;86(2):185\u201395.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"780_CR69","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jmedgenet-2011-100125","volume":"48","author":"AW El-Hattab","year":"2011","unstructured":"El-Hattab AW, Fang P, Jin W, Hughes JR, Gibson JB, Patel GS, et al. Int22h-1\/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. J Med Genet. 2011;48(12):840\u201350.","journal-title":"J Med Genet"},{"issue":"3","key":"780_CR70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/humu.22497","volume":"35","author":"L Vanmarsenille","year":"2014","unstructured":"Vanmarsenille L, Giannandrea M, Fieremans N, Verbeeck J, Belet S, Raynaud M, et al. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. Hum Mutat. 2014;35(3):377\u201383.","journal-title":"Hum Mutat"},{"key":"780_CR71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-015-0045-4","volume":"10","author":"IF Mata","year":"2015","unstructured":"Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson\u2019s disease. Mol Neurodegener. 2015;10:50.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"780_CR72","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/mds.26828","volume":"31","author":"CH Shi","year":"2016","unstructured":"Shi CH, Zhang SY, Yang ZH, Yang J, Shang DD, Mao CY, et al. A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification. Mov Disord. 2016;31(12):1905\u20139.","journal-title":"Mov Disord"},{"issue":"1","key":"780_CR73","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1212\/NXG.0000000000000009","volume":"1","author":"S Lesage","year":"2015","unstructured":"Lesage S, Bras J, Cormier-Dequaire F, Condroyer C, Nicolas A, Darwent L, et al. Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease. Neurol Genet. 2015;1(1):e9.","journal-title":"Neurol Genet"},{"issue":"5","key":"780_CR74","doi-asserted-by":"crossref","first-page":"e36458","DOI":"10.1371\/journal.pone.0036458","volume":"7","author":"S Edvardson","year":"2012","unstructured":"\u2022 Edvardson S, Cinnamon Y, Ta-Shma A, Shaag A, Yim YI, Zenvirt S, et al. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS One. 2012;7(5):e36458. Edvarson et al. provide the first description of DNAJC6 mutations in two siblings with very severe childhood-onset Parkinsonism.","journal-title":"PLoS One"},{"issue":"3","key":"780_CR75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","volume":"19","author":"C Koroglu","year":"2013","unstructured":"Koroglu C, Baysal L, Cetinkaya M, Karasoy H, Tolun A. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. Parkinsonism Relat Disord. 2013;19(3):320\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"780_CR76","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","volume":"79","author":"S Olgiati","year":"2016","unstructured":"\u2022\u2022 Olgiati S, Quadri M, Fang M, Rood JP, Saute JA, Chien HF, et al. DNAJC6 mutations associated with early-onset Parkinson\u2019s disease. Ann Neurol. 2016;79(2):244\u201356. In this report, Olgiati et al. have identified DNAJC6 variants in patients with early-onset PD without prominent additional neurological signs or symptoms.","journal-title":"Ann Neurol"},{"issue":"2","key":"780_CR77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","volume":"79","author":"LE Elsayed","year":"2016","unstructured":"Elsayed LE, Drouet V, Usenko T, Mohammed IN, Hamed AA, Elseed MA, et al. A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson\u2019s disease. Ann Neurol. 2016;79(2):335\u20137.","journal-title":"Ann Neurol"},{"issue":"2","key":"780_CR78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.24587","volume":"79","author":"S Olgiati","year":"2016","unstructured":"Olgiati S, Quadri M, Mandemakers W, Bonifati V. Reply. Ann Neurol. 2016;79(2):337\u20138.","journal-title":"Ann Neurol"},{"issue":"3","key":"780_CR79","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","volume":"98","author":"S Lesage","year":"2016","unstructured":"\u2022\u2022 Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, et al. Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/parkin-dependent mitophagy. Am J Hum Genet. 2016;98(3):500\u201313. Lesage et al. used an interesting approach, selecting patients with early-onset PD from consanguineous parents, and also provide functional evidence for the pathogenicity of VPS13C mutations.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"780_CR80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmedgenet-2015-103459","volume":"53","author":"S Sudhaman","year":"2016","unstructured":"Sudhaman S, Prasad K, Behari M, Muthane UB, Juyal RC, Thelma BK. Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile parkinsonism. J Med Genet. 2016;53(7):450\u20136.","journal-title":"J Med Genet"},{"issue":"2","key":"780_CR81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.26824","volume":"32","author":"H Khodadadi","year":"2017","unstructured":"\u2022\u2022 Khodadadi H, Azcona LJ, Aghamollaii V, Omrani MD, Garshasbi M, Taghavi S, et al. PTRHD1 (C2orf79) mutations lead to autosomal-recessive intellectual disability and parkinsonism. Mov Disord. 2017;32(2):287\u201391. Khodadadi et al. report PTRHD1 mutations from one Iranian family and correctly relate to Jaberi et al.\u2019s previous report on a family with similar phenotype.","journal-title":"Mov Disord"},{"issue":"7","key":"780_CR82","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.26627","volume":"31","author":"E Jaberi","year":"2016","unstructured":"Jaberi E, Rohani M, Shahidi GA, Nafissi S, Arefian E, Soleimani M, et al. Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction. Mov Disord. 2016;31(7):1004\u201311.","journal-title":"Mov Disord"},{"issue":"19","key":"780_CR83","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/WNL.0b013e318219fb42","volume":"76","author":"A Puschmann","year":"2011","unstructured":"Puschmann A, Pfeiffer RF, Stoessl AJ, Kuriakose R, Lash JL, Searcy JA, et al. A family with parkinsonism, essential tremor, restless legs syndrome, and depression. Neurology. 2011;76(19):1623\u201330.","journal-title":"Neurology"},{"issue":"17","key":"780_CR84","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1093\/hmg\/ddw206","volume":"25","author":"EM Hill-Burns","year":"2016","unstructured":"Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, et al. Identification of genetic modifiers of age-at-onset for familial Parkinson\u2019s disease. Hum Mol Genet. 2016;25(17):3849\u201362.","journal-title":"Hum Mol Genet"},{"key":"780_CR85","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Lubbe SJ, Escott-Price V, Gibbs JR, Nalls MA, Bras J, Price TR, et al. Additional rare variant analysis in Parkinson\u2019s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance. Hum Mol Genet. 2016; doi:\n10.1093\/hmg\/ddw348\n\n. Lubbe et al. used data from exome sequencing and NeuroX analyses from 7900 PD cases to study possible oligogenic mechanisms in PD.","DOI":"10.1093\/hmg\/ddw348"},{"issue":"6","key":"780_CR86","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1093\/brain\/awx076","volume":"140","author":"Z Gan-Or","year":"2017","unstructured":"Gan-Or Z, Ruskey JA, Spiegelman D, Arnulf I, Dauvilliers Y, Hogl B, et al. Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. Brain. 2017;140(6):e32.","journal-title":"Brain"},{"issue":"Pt 1","key":"780_CR87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/brain\/aww261","volume":"140","author":"A Puschmann","year":"2017","unstructured":"Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, et al. Heterozygous PINK1 p.G411S increases risk of Parkinson\u2019s disease via a dominant-negative mechanism. Brain. 2017;140(Pt 1):98\u2013117.","journal-title":"Brain"},{"issue":"6","key":"780_CR88","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1093\/brain\/awx077","volume":"140","author":"A Puschmann","year":"2017","unstructured":"Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, et al. Reply: heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. Brain. 2017;140(6):e33.","journal-title":"Brain"},{"issue":"12","key":"780_CR89","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S1474-4422(16)30203-4","volume":"15","author":"J Trinh","year":"2016","unstructured":"Trinh J, Gustavsson EK, Vilarino-Guell C, Bortnick S, Latourelle J, McKenzie MB, et al. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study. Lancet Neurol. 2016;15(12):1248\u201356.","journal-title":"Lancet Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-017-0780-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0780-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0780-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T01:29:54Z","timestamp":1503106194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-017-0780-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s11910-017-0780-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]},"article-number":"66"}}